Clinical Trial Detail

NCT ID NCT03085056
Title Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

thyroid gland cancer

Therapies

Paclitaxel + Trametinib

Age Groups: senior adult

No variant requirements are available.